ANTONAZZO IPPAZIO COSIMO

Mazzaglia, G., Antonazzo, I., Mol, P. (2024). Risk management and drug utilization research. In Drug Utilization Research: Methods and Applications (pp. 428-436). wiley [10.1002/9781119911685.ch42]. Detail

Brauer, M., Roth, G., Aravkin, A., Zheng, P., Abate, K., Abate, Y., et al. (2024). Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. THE LANCET, 403(10440 (18–24 May 2024)), 2162-2203 [10.1016/s0140-6736(24)00933-4]. Detail

Ferrara, P., Antonazzo, I., Zamparini, M., Fornari, C., Borrelli, C., Boarino, S., et al. (2024). Epidemiology of SLE in Italy: an observational study using a primary care database. LUPUS SCIENCE & MEDICINE, 11(1) [10.1136/lupus-2024-001162]. Detail

Antonazzo, I., Rozza, D., Cortesi, P., Fornari, C., Zanzottera Ferrari, E., Paris, C., et al. (2024). Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database. ACTA DIABETOLOGICA [10.1007/s00592-024-02359-1]. Detail

Antonazzo, I., Gribaudo, G., La Vecchia, A., Ferrara, P., Piraino, A., Cortesi, P., et al. (2024). Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review. PHARMACOECONOMICS, 42(12), 1329-1343 [10.1007/s40273-024-01428-1]. Detail